Loading...
 
 26510 99294
 Λεωφόρος Σταύρου Νιάρχου, 455 00 Ιωάννινα

Latest posts from
What is New in Respiratory Medicine
Facebook Group

  • Tuesday 13 Oct 2020

    https://rdcu.be/b8rc3

    Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.

    Ranitidine bismuth citrate suppressed SARS-CoV-2 replication, leading to decreased viral loads in both upper and lower respiratory tracts, and relieved virus-associated pneumonia in a golden Syrian hamster model. In vitro studies showed that ranitidine bismuth citrate and its related compounds exhibited inhibition towards both the ATPase and DNA-unwinding activities of the SARS-CoV-2 helicase via an irreversible displacement of zinc(II) ions from the enzyme by bismuth(III) ions.

    Drug used to treat Helicobacter pylori infection reduces SARS-CoV-2 viral loads in lungs and alleviates virus-associated pneumonia in a golden Syrian hamster model.

     
  • Tuesday 13 Oct 2020

    Now, a new study published on the preprint server bioRxiv sheds light on the mechanism behind brain involvement in the COVID-19 pandemic. A team of researchers at the Krembil Research Institute and the University of Toronto in Canada aimed to understand further the potential mechanisms underlying SA...

     
  • Tuesday 13 Oct 2020

    NIH COVID-19 Guideline Oct 8 Update

    Read this summary to learn about the key changes and additions to the guidelines, including the latest recommendations on managing COVID-19.

     
  • Monday 12 Oct 2020

    Risks for cold frequency vary by sex: role of asthma, age, TLR7 and leukocyte subsets.

    People with asthma cases reported more colds per year and had lower baseline TLR7 gene expression than controls. Associations between many variables and cold frequency differed between women and men. In women, high blood neutrophil counts, and younger age, but not exposure to children, were independently associated with more frequent colds. In men, low TLR7 expression and high CLEC4C gene expression were independently associated with more frequent colds. Poor asthma symptom control was independently associated with reduced TLR8 gene expression and high body mass index. In conclusion asthma, age and markers of inflammation and antiviral immunity in peripheral blood are associated with frequent colds. Interestingly, the variables associated with cold frequency differed between women and men.

    Viral respiratory infections are usually benign but can trigger asthma exacerbations. The factors associated with upper respiratory tract infection (cold) frequency are not fully understood, nor is it clear whether such factors differ between women and men. To determine which immunological and clini...

     
  • Monday 12 Oct 2020

    Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial

    The timing of ICS dose when self-titrated to β2-agonist use is more important than total ICS dose in reducing severe exacerbation risk in mild asthma, when associated with greater overall use of as-needed β2-agonist.

    Introduction In mild asthma, as-needed budesonide–formoterol is superior or noninferior to maintenance budesonide plus as-needed short-acting β2-agonist in reducing severe exacerbations. In this pre-specified analysis, we investigated patterns of inhaled corticosteroid (ICS) and β2-agonist use i...

     
  • Monday 12 Oct 2020

    Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena.

    A significant number of patients who meet currently approved indications for anti-IL5 mAbs show suboptimal response to them in real-life clinical practice, particularly if they are on high doses of prednisone. Monitoring blood eosinophil count is not helpful to identify these patients. The concern of worsening of symptoms associated with immune-complex mediated complement activation in a small proportion of these patients highlights the relevance of recognising airway autoimmune phenomena and this requires further evaluation.

    Background In clinical trials, the two anti-interleukin (IL)-5 monoclonal antibodies (mAbs: mepolizumab and reslizumab) approved to treat severe eosinophilic asthma reduce exacerbations by ∼50–60%. Objective To observe response to anti-IL-5 mAbs in a real-life clinical setting, and to evaluate p...

     
  • Monday 12 Oct 2020

    Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2.

    Pediatric patients with SARS–CoV-2 are at risk for critical illness with severe COVID-19 and multisystem inflammatory syndrome in children (MIS-C). Cytokine profiling and examination of peripheral blood smears may distinguish between patients with MIS-C and those with severe COVID-19.

    9Division of Hematology, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

     
  • Monday 12 Oct 2020

    Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview.

    COVID-19 is a progressive viral pneumonia with a broad spectrum of clinical manifestations. Studies on the clinical and radiological manifestations of COVID-19 show that SARS-CoV-2 infection can present with extrapulmonary features, such as Renal dysfunction, Gastrointestinal complications, Liver dysfunction, Cardiac manifestation, Mediastinal lymphadenopathy, Neurological findings, Hematological manifestations, Vascular abnormalities, Vascular abnormalities, Reproductive system involvement and Ocular symptoms.

    COVID-19 is principally a respiratory illness and pulmonary manifestations constitute main presentations of the disease. According to the reported studies, SARS-CoV-2 infection is not limited to the respiratory system and other organs can be also affected. Renal dysfunction, gastrointestinal complic...

     
  • Sunday 11 Oct 2020

    SARS-CoV-2 infection induces endothelial cell activation, hypercoagulability, and enhanced inflammatory reaction. • Immunothrombosis is a major contributor in the COVID-19 worsening process. • Males, citizens with obesity, diabetes mellitus, or arterial hypertension, and patients with cardiovascular disease are at high risk for severe COVID-19. • VAS proposes a COVID-19-oriented primary health care network for patients with vascular disease and cardiovascular risk factors (VD-CVR). • Adherence to the antihypertensive, antiplatelet, antidiabetic, and lipid-lowering treatment and prevention of VTE are essential for the decrease of the risk for COVID-19 worsening in patients with VD-CVR. • For hospitalized patients with VD-CVR and COVID-19, VAS recommends early administration of thromboprophylaxis with an intermediate dose of LMWH or UFH and a regular evaluation of the biological efficacy of the treatment.

    COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial

     
  • Sunday 11 Oct 2020

    Hypercytokinaemic immune dysregulation in COVID19 is known as cytokine storm syndrome. Interleukin-6 levels ≥80 pg/mL predict an increased risk of respiratory failure and death, and immunomodulatory therapy is an area of urgent investigation. buff.ly/2SQWVE9

    The concept of coronavirus disease 2019 (COVID-19)-related cytokine storm syndrome (COVID-CSS) emerged early in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to explain why some patients exposed to this virus become critically ill with acute respiratory distress syndrome,...

     
  • Sunday 11 Oct 2020

    New data on the long-term efficacy and safety of dupilumab are very reassuring to patients with asthma, explained J. Allen Meadows, MD, president of the American College of Allergy, Asthma & Immunology

    New data on the long-term efficacy and safety of dupilumab are very reassuring to patients with asthma, explained J. Allen Meadows, MD, president of the American College of Allergy, Asthma & Immunology.

     
  • Sunday 11 Oct 2020

    The ABCs of Granulomatous Lung Diseases: Age-associated B Cells

    At the mention of B cells, your likely first thought is the production of antibodies, mostly beneficially directed against microbial threats but also potentially pathogenic, as when allergy is triggered in a susceptible host by excessive antigenic exposure or when inappropriate self-sensitization le...

     
  • Sunday 11 Oct 2020

    Review of viral ARDS pathogenesis, how it informs evolving models of #COVID19, and how hallmarks of ageing explain the age-related morbidity and mortality of severe COVID-19 buff.ly/2GMBG4b

    The coronavirus disease 2019 (COVID-19) pandemic has elicited a swift response by the scientific community to elucidate the pathogenesis of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-induced lung injury and develop effective therapeutics. Clinical data indicate that severe COVID-19...

     
  • Sunday 11 Oct 2020

    Congratulations to Professor Sir Stephen Holgate awarded a knighthood for services to medical research. Well deserved.

     
  • Saturday 10 Oct 2020

    Great read on the sputum macrophage diversity & activation in #SevereAsthma and the role of severity and inflammatory phenotype

     
  • Saturday 10 Oct 2020

    Risk of Severe COVID May Depend on Your Type of Asthma, Experts Say. A new article in @usnews says folks whose #asthma is spurred on by allergies don't appear to have an increased risk of life-threatening illness if they contract COVID-19.

    US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

     
  • Saturday 10 Oct 2020

    Cellular Senescence: Friend or Foe to Respiratory Viral Infections? | European Respiratory Society https://buff.ly/2SCAvGK

    Cellular senescence permanently arrests the replication of various cell types and contributes to age-associated diseases. In particular, cellular senescence may enhance chronic lung diseases including chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. However, the role cellular...

     
  • Saturday 10 Oct 2020

    Infectious Disease Transmission Models to Predict, Evaluate, and Improve Understanding of COVID-19 Trajectory and Interventions

    Coronavirus disease (COVID-19) has spread rapidly around the world with devastating consequences. Large questions loom about how this epidemic will proceed and what interventions can slow the spread. In the face of a global pandemic with a novel infectious agent, policymakers face the difficult task...

     
  • Saturday 10 Oct 2020

    By Amy Orciari HermanEdited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHMCheck out some of the latest developments in

     
  • Saturday 10 Oct 2020

    Silent transmission in healthcare settings may be a risk.

     
317 Αντικείμενα. Σελίδα 2/16
1 2 3 4 5 6 7 8 9 10
 
Developed by LogicOne